[ALNY] QoQ Quarter Result on 31-Dec-2019 [#Q4]

Stock
[ALNY] Alnylam Pharmaceuticals, Inc.
Announcement Date
13-Feb-2020
Financial Year
2019
Quarter
31-Dec-2019 [#Q4]
Profit Trend
QoQ- -32.44%
YoY- -30.62%
Quarter Report
ALNY's Result
ALNY's Financial Summary
View:
Show?
Quarter Result
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
Revenue 125,853 103,962 99,476 71,681 70,061 44,714 33,294 142.07%
PBT -252,452 -177,903 -181,646 -276,583 -208,929 -218,521 -181,220 24.65%
Tax 839 1,326 575 -398 -394 960 695 13.33%
NP -253,291 -179,229 -182,221 -276,185 -208,535 -219,481 -181,915 24.61%
Tax Rate - - - - - - - -
Total Cost 379,144 283,191 281,697 347,866 278,596 264,195 215,209 45.71%
Ratio Analysis
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
NP Margin -201.26 -172.40 -183.18 -385.30 -297.65 -490.86 -546.39 -48.52%
Per Share
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
EPS -2.18 -1.56 -1.62 -2.47 -1.92 -2.02 -1.73 16.61%
EPS Diluted -2.18 -1.56 -1.62 -2.47 -1.92 -2.02 -1.73 16.61%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.